和康生

-0.65 (-1.75%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

36.4059成交張數11.20本益比2.18股價淨值比5.49%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	20	15	26.3%	2.33	16.71	20.0%	15.6%	0.8	0.6
2026Q1	20	16	18.3%	3.32	18.14	17.5%	14.7%	0.8	0.7
2025Q4	19	15	18.8%	3.21	17.15	18.2%	15.3%	1.0	0.9
2025Q3	17	15	13.7%	4.19	16.43	16.7%	14.4%	0.8	0.6
2025Q2	17	14	16.5%	3.43	15.75	15.2%	12.8%	0.4	0.3
2025Q1	17	15	12.9%	4.18	16.48	14.8%	13.1%	0.7	0.7
2024Q4	16	14	13.1%	4.03	15.42	13.9%	12.4%	0.8	0.7
2024Q3	15	13	12.9%	3.79	14.98	11.5%	10.1%	1.2	1.1
2024Q2	16	13	15.1%	3.09	14.94	11.1%	9.6%	0.4	0.4
2024Q1	15	14	9.2%	4.82	15.21	11.1%	10.1%	0.5	0.4
2023Q4	15	14	8.8%	4.72	15.30	12.5%	11.3%	0.6	0.5
2023Q3	15	14	11.3%	3.72	15.40	14.6%	13.1%	0.2	0.1
2023Q2	15	13	12.9%	3.19	15.54	15.3%	13.6%	0.7	0.7
2023Q1	15	13	10.0%	7.08	15.87	13.0%	11.8%	0.2	0.2
2022Q4	14	13	10.5%	6.56	15.30	11.4%	10.3%	0.8	0.8
2022Q3	14	12	9.3%	7.27	16.23	9.3%	8.4%	0.7	0.7
2022Q2	13	12	8.6%	7.59	15.62	9.4%	8.5%	0.6	0.6
2022Q1	13	12	8.5%	7.86	15.14	8.5%	7.7%	0.6	0.5
2021Q4	13	11	9.8%	6.75	14.83	8.8%	7.9%	0.5	0.4
2021Q3	12	11	9.4%	6.74	14.61	9.6%	8.7%	0.4	0.3
2021Q2	10	9	11.1%	4.80	13.00	8.7%	7.6%	0.1	0.1
2021Q1	10	9	9.8%	5.32	12.70	8.6%	7.7%	0.2	0.2
2020Q4	10	9	10.1%	4.99	12.38	7.4%	5.9%	0.7	0.6
2020Q3	9	8	9.8%	5.01	12.09	6.0%	4.8%	0.3	0.3
2020Q2	10	8	15.2%	3.21	11.92	7.0%	5.3%	-0.2	-0.2
2020Q1	10	9	11.1%	4.43	12.40	7.4%	6.0%	-0.0	-0.1
2019Q4	12	9	28.2%	1.99	12.26	7.1%	5.2%	0.5	0.5
2019Q3	12	8	27.0%	2.03	12.15	7.1%	5.3%	0.4	0.3
2019Q2	12	8	31.1%	1.80	11.87	7.1%	5.0%	-0.1	-0.1
2019Q1	12	8	26.4%	2.07	11.99	6.7%	4.9%	0.2	0.1
2018Q4	11	8	25.8%	2.05	11.90	7.0%	5.1%	0.3	0.3
2018Q3	11	8	25.5%	7.97	11.79	6.5%	4.8%	0.4	0.3
2018Q2	11	8	27.4%	7.30	11.54	5.4%	3.9%	0.5	0.5
2018Q1	11	8	26.6%	8.76	11.36	3.6%	2.6%	0.5	0.4
2017Q4	11	8	27.9%	7.05	11.24	2.0%	1.4%	0.4	0.4
2017Q3	11	8	27.3%	8.21	11.19	2.0%	1.4%	0.1	0.0
2017Q2	11	8	27.4%	8.18	11.09	0.9%	0.6%	-0.0	-0.0
2017Q1	11	8	27.9%	7.55	10.96	-0.6%	-0.5%	-0.1	-0.3
2016Q4	11	8	28.8%	6.55	11.03	–	–	0.1	-0.0
2016Q3	11	8	29.2%	6.24	10.99	–	–	0.4	0.2